Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

Access to Document

@article{66640fce5b344c23a555e7ec591a7e41,

title = "Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)",

author = "Chris Webber and Michael Patton and Bonten, \{Marc J.M.\}",

year = "2017",

month = dec,

day = "18",

doi = "10.1016/j.vaccine.2017.10.056",

language = "English",

volume = "35",

pages = "7078",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Limited",

number = "51",

}

TY - JOUR

T1 - Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)

AU - Webber, Chris

AU - Patton, Michael

AU - Bonten, Marc J.M.

PY - 2017/12/18

Y1 - 2017/12/18

UR - https://www.scopus.com/pages/publications/85035084084

U2 - 10.1016/j.vaccine.2017.10.056

DO - 10.1016/j.vaccine.2017.10.056

M3 - Letter

AN - SCOPUS:85035084084

SN - 0264-410X

VL - 35

SP - 7078

JO - Vaccine

JF - Vaccine

IS - 51

ER -